Duke Radiation Oncology is proud to represent our Department during ASTRO 2026. Please click here to search Duke-authored presentations and posters from our faculty, trainees and staff or scroll down for a faculty and trainee listing of presentations and posters.
| Date | Time | Title | Presenter |
|---|---|---|---|
| Sept. 27 | 3-4 p.m. | 2227 - Outcomes Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Single Institution Experience | Andrew Skipper, MD |
| Sept. 30 | 8-9 a.m. | QP 39 - Imaging for Positioning and Motion Management | Anna Rodrigues, PhD, MS |
| Sept. 29 | 3:45-5 p.m. | EDU 51 - Mythbusting Radiation Oncology: Communicating the Truth and Value of Radiotherapy to the Public, Patients, Providers and Policymakers | Avinash Chaurasia, MD (adjunct) |
| Sept. 28 | 5:10-5:15 p.m. | 1092 - Coronary Artery Calcifications and Major Adverse Cardiac Events after Radiation Therapy for Locally-Advanced Non-Small Cell Lung Cancer | Christopher Kelsey, MD |
| Sept. 29 | 12:30-1:45 p.m. | ASTRO GI Guideline Session: Radiation Therapy for Gastric Cancer and Pancreatic Cancer: A Case-Based Interactive Discussion | Christopher Willett, MD |
| Sept. 30 | 9:15-10:30 a.m. | SS 49 - Smart Planning and Adaptation | Chunhao Wang, PhD |
| Sept. 29 | 12:30-1:45 p.m. | EDU 38 - At the Margins: Navigating Challenging Vulvar and Vaginal Cancers | Diandra Ayala-Peacock, MD |
| Sept. 27 | 3-4 p.m. | 2230 - Efficacy and Safety of Fractionated Stereotactic Radiosurgery for the Treatment of Large Intracranial Arteriovenous Malformations | Eugene Vaios, MD, MBA |
| Sept. 27 | 3-4 p.m. | 2241 - Neurocognitive Outcomes in Patients with Brain Metastases: A Systematic Review of Past Findings and Future Directions | Eugene Vaios, MD, MBA |
| Sept. 29 | 4:05-4:10 p.m. | 1143 - A Blood-based DNA Methylation Signature for Non-invasive Diagnosis and Prediction of Clinical Outcomes in Patients with Glioblastoma Enrolled on the Phase II Randomized VERTU Trial | Eugene Vaios, MD, MBA |
| Sept. 28 | 10:45 a.m.-12 p.m. | EDU 21 - Improving Communication to Enhance Patient Care in the Palliative Setting | Jared Robbins, MD |
| Sept. 29 | 5:20-5:25 p.m. | 1175 - Radiotherapy Dose De-Escalation in HPV-Associated Cancers of the Oropharynx Using Metabolic Signature from Interim 18FDG-PET/CT | Jared Robbins, MD |
| Sept. 27 | 5:20-5:30 p.m. | 145 - Federated Deep Ensemble Learning for MRI-Based Brain Metastasis Segmentation: An International Multi-Center Development | Jingtong Zhao, PhD |
| Sept. 29 | 12:30-1:45 p.m. | 3009 - A Simple Motion Robust Planning Technique for Lung SBRT | John Ginn, PhD |
| Sept. 29 | 2:15-3:30 p.m. | 3709 - Radiation Oncology Physician Workforce Populations: A Snapshot from the 2025 ASTRO Annual Member Survey | Joseph Salama, MD |
| Sept. 28 | 5:32-5:47 p.m. | Closing the Loop: Using NLP and LLMs to Extract and Score Toxicities Post-RT to Drive Timely Interventions and Quality Improvement | Julian Hong, MD, MS (alumnus) |
| Sept. 28 | 10:45 a.m.-12:15 p.m. | EDU 24 - Comprehensive eContouring for GI, Head and Neck and Thoracic Cancers | Manisha Palta, MD |
| Sept. 29 | 3:45-5 p.m. | 3469 - Prognostic Impact of Endobronchial Involvement in Ultracentral NSCLC Treated with Stereotactic Ablative Radiotherapy | Marie Fort, MD |
| Sept. 28 | 8:02-8:17 a.m. | Radiobiologic Mechanisms of Spatially Fractionated RT: Microenvironmental and Dose-Pattern Effects | Mark Oldham, PhD |
| Sept. 29 | 5:40-5:45 p.m. | 1179 - Elective Nodal Irradiation to 44 Gy with Sequential IMRT Boost in HPV-Positive Oropharyngeal Squamous Cell Carcinoma | Michael Chisam, MD (alumnus) |
| Sept. 29 | 3:15-3:25 p.m. | Discussant (SS 34 - The Automated Clinic: AI-Powered Contouring, Monitoring, and Data Extraction) | Q. Jackie Wu, PhD |
| Sept. 29 | 3:45-5 p.m. | 3462 - Stereotactic Body Radiation Therapy is Associated with Accelerated Pulmonary Fibrosis in Patients with Interstitial Lung Disease: A Comprehensive Radiologic Analysis | Seifallah Emam, MS (alumnus) |
| Sept. 28 | 3-4 p.m. | 2851 - Moderate Hypofractionated Radiation Therapy for Rosai-Dorfman Disease | Xavier Rodriguez-Lopez, MD, BS |
| Sept. 29 | 12:30-1:45 p.m. | 3181 - Clinical Impact of Dynamic Collimator for Single-Isocenter Multi-Target SRS Evaluated through Physician Rating and Dosimetric Analysis | Yibo Xie, PhD |
| Sept. 29 | 2:35-2:45 p.m. | 300 - A Novel Therapeutic Approach Using citVIM-specific CAR-T cells and Radiotherapy to Target NSCLC and Pancreatic Cancer Cells | Yorleny Vicioso Mora, MD, PhD, BS |
| Sept. 30 | 10:45-11:45 a.m. | QP 44 - Biology and Prevention of Radiation-Induced Injury | Yvonne Mowery, MD, PhD, BS (alumnus) |
| Sept. 29 | 12:30-1:45 p.m. | SS 30 - Optimizing Therapy, Toxicity, and Supportive Care in Head & Neck Cancers | Yvonne Mowery, MD, PhD, BS (alumnus) |